Document is current
Any future updates will be listed below
-
Authors
Lin, Qiupeng
Zong, Yuan
Xue, Chenxiao
Wang, Shengxing
Jin, Shuai
Zhu, Zixu
Wang, Yanpeng
Anzalone, Andrew V.
Raguram, Aditya
Doman, Jordan L. https://orcid.org/0000-0002-9887-0391
Liu, David R. https://orcid.org/0000-0002-9943-7557
Gao, Caixia https://orcid.org/0000-0003-3169-8248
- License Information
-
More Information
Article History
Received: 12 December 2019
Accepted: 11 February 2020
First Online: 16 March 2020
Competing interests
: The authors have submitted a patent application based on the results reported in this paper. D.R.L. is a consultant for and co-founder of Beam Therapeutics, Prime Medicine, Pairwise Plants, and Editas Medicine—companies that use genome editing.
